MTOR and colorectal carcinoma: The results showed that BEZ235 combined with BMS-1166 inhibits the phosphorylation of the downstream effector molecules (S6K and elF4EBP1) of the PI3K/mTOR pathway in CRC cell lines (Figure 4D).